Compare with LYKA LABS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMI ORGANICS vs LYKA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMI ORGANICS LYKA LABS AMI ORGANICS/
LYKA LABS
 
P/E (TTM) x - 10.1 - View Chart
P/BV x 19.8 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 AMI ORGANICS   LYKA LABS
EQUITY SHARE DATA
    AMI ORGANICS
Mar-21
LYKA LABS
Mar-21
AMI ORGANICS/
LYKA LABS
5-Yr Chart
Click to enlarge
High RsNA36 0.0%   
Low RsNA13 0.0%   
Sales per share (Unadj.) Rs108.130.1 359.7%  
Earnings per share (Unadj.) Rs17.1-3.5 -487.4%  
Cash flow per share (Unadj.) Rs18.5-0.6 -2,999.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %NM0- 
Book value per share (Unadj.) Rs53.0-9.0 -589.4%  
Shares outstanding (eoy) m31.5028.69 109.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x00.8 0.0%   
Avg P/E ratio x0-6.9 0.0%  
P/CF ratio (eoy) x0-39.3 0.0%  
Price / Book Value ratio x0-2.7 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m0694 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m210146 144.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,406863 394.9%  
Other income Rs m1416 88.3%   
Total revenues Rs m3,420878 389.5%   
Gross profit Rs m802186 431.9%  
Depreciation Rs m4283 50.3%   
Interest Rs m56259 21.7%   
Profit before tax Rs m717-141 -507.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m177-41 -437.4%   
Profit after tax Rs m540-101 -535.1%  
Gross profit margin %23.521.5 109.4%  
Effective tax rate %24.728.7 86.2%   
Net profit margin %15.9-11.7 -135.5%  
BALANCE SHEET DATA
Current assets Rs m2,162291 742.5%   
Current liabilities Rs m1,660492 337.2%   
Net working cap to sales %14.7-23.3 -63.2%  
Current ratio x1.30.6 220.2%  
Inventory Days Days1187 12.9%  
Debtors Days Days129367 35.2%  
Net fixed assets Rs m1,9701,445 136.3%   
Share capital Rs m315287 109.8%   
"Free" reserves Rs m1,354-545 -248.6%   
Net worth Rs m1,669-258 -647.1%   
Long term debt Rs m7261,514 48.0%   
Total assets Rs m4,1331,737 238.0%  
Interest coverage x13.80.5 3,027.8%   
Debt to equity ratio x0.4-5.9 -7.4%  
Sales to assets ratio x0.80.5 165.9%   
Return on assets %14.49.1 158.1%  
Return on equity %32.339.1 82.7%  
Return on capital %32.39.4 343.7%  
Exports to sales %50.80-   
Imports to sales %14.60-   
Exports (fob) Rs m1,729NA-   
Imports (cif) Rs m499NA-   
Fx inflow Rs m1,7290-   
Fx outflow Rs m5270-   
Net fx Rs m1,2020-   
CASH FLOW
From Operations Rs m27188 308.0%  
From Investments Rs m-1,004-2 62,354.0%  
From Financial Activity Rs m721-118 -611.2%  
Net Cashflow Rs m-11-31 36.1%  

Share Holding

Indian Promoters % 41.1 20.0 205.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.8 3.9 224.7%  
FIIs % 2.5 2.1 121.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 59.0 80.0 73.7%  
Shareholders   92,459 20,672 447.3%  
Pledged promoter(s) holding % 0.0 18.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMI ORGANICS With:   EMMESSAR CHM  COLINZ LABOR  ZOTA HEALTH CARE  HIKAL.  CIAN HEALTHCARE  



Today's Market

Sensex Zooms 600 Points, Nifty Tops 17,250; Bajaj Finserv & Tech Mahindra Top Gainers(10:30 am)

Asian share markets are trading in positive territory as investors became cautiously optimistic the new Omicron variant might not cause a widespread global economic.

Related Views on News

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMI ORGANICS SHARE PRICE


Nov 30, 2021 03:36 PM

TRACK AMI ORGANICS

  • Track your investment in AMI ORGANICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMI ORGANICS 5-YR ANALYSIS

COMPARE AMI ORGANICS WITH

MARKET STATS